faCellitate

company

About

faCellitate is a life science tools company targeting customers in drug discovery, toxicology, industrial biotech and stem cell research.

  • Mannheim,Baden-Wurttemberg,Germany
  • 11 - 50

Details

Last Funding Type
Seed
Last Funding Money Raised
€3.70M
Industries
Biotechnology
Founded date
Jan 1, 2019
Number Of Employee
11 - 50
Operating Status
Active
Legal Name
faCellitate GmbH.
Also Known As
faCellitate - Combine Function with Your Labware

faCellitate develops polymeric platforms that aim at supporting cancer and stem cell research, drug discovery, toxicology, and tissue engineering. The platform facilitates cellular interaction, significantly improving cell culture in biological research.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
€3.70M
faCellitate has raised a total of €3.70M in funding over 2 rounds. Their latest funding was raised on Sep 7, 2022 from a Seed round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Sep 7, 2022 Seed €3.70M 6 High-Tech Grunderfonds
SARSTEDT
Detail

Investors

Number of Lead Investors
Number of Investors
2
6
faCellitate is funded by 6 investors. High-Tech Grunderfonds and SARSTEDT are the most recent investors.
Investor Name Lead Investor Funding Round
High-Tech Grunderfonds Yes Seed
SARSTEDT Yes Seed
ARVE Capital Seed
Chemovator Seed
R3 Seed
ROI land investment Seed

Employee Profiles

Number of Employee Profiles
1
faCellitate has 1 current employee profiles, including Executive Simon Widmaier
Executive